Yongxin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yongxin Li has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Chunzhao Liu
State Key Laboratory of Bio-Fibers and Eco-Textiles, Institute of Biochemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao 266071, China
7 shared publications Chunlei Liu
5 shared publicationsShuo Zhang
State Key Laboratory of Bio‐fibers and Eco‐textiles Institute of Biochemical Engineering The Affiliated Qingdao Central Hospital of Qingdao University College of Materials Science and Engineering Qingdao University Qingdao 266071 China
5 shared publicationsChunzhao Liu
State Key Laboratory of Bio‐fibers and Eco‐textiles Institute of Biochemical Engineering College of Materials Science and Engineering Qingdao University Qingdao China
4 shared publications- Pui-Chi Lo
Department of Biomedical Sciences and Tung Biomedical Sciences Centre City University of Hong Kong Kowloon Hong Kong China
4 shared publications Xiaopeng Lan
Department of Urology Qingdao Central Hospital University of Health and Rehabilitation Sciences Qingdao 266071 China
4 shared publications
Latest Publications
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (42) , 13204-13214
Dual mitochondrial-targeting nanoplatform integrating cuproptosis and pyroptosis for robust antitumor immune activation
A dual mitochondrial-targeting nanoplatform integrating cuproptosis and pyroptosis triggers robust immunogenic cell death.
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (42) , 13204-13214
Dual mitochondrial-targeting nanoplatform integrating cuproptosis and pyroptosis for robust antitumor immune activation
A dual mitochondrial-targeting nanoplatform integrating cuproptosis and pyroptosis triggers robust immunogenic cell death.
- Open Access
- 17 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (35) , e71609
Ferritin‐Inspired Mineralized Iron Phosphate Nanominerals for Precision Ferroptosis–Immunotherapy via Controlled Iron Storage and Release
Ferroptosis provides promising method for tumor therapy but is limited by the low efficiency and safety concerns of conventional iron delivery systems. Herein, we report efficient ferritin‐mimetic nanominerals engineered via a small molecule‐mediated iron phosphate mineralization strategy, which emulates the natural iron storage and release processes to selectively trigger tumor ferroptosis. Using two ferroptosis inducers, palbociclib and Fin56, as model small molecules, the resulting nanominerals exhibit uniform size distribution, robust stability, and 72% iron incorporation efficiency, enabling precisely controlled ferrous ion release and dual‐drug co‐delivery within tumor tissues to achieve a triple amplification of ferroptosis. The amplified ferroptosis response further elicits a potent antitumor immune effect through immunogenic cell death, ultimately resulting in remarkable therapeutic efficacy with minimal side effects both in vitro and in vivo. This small molecule‐mediated iron phosphate mineralization strategy offers a superior alternative to traditional coordination self‐assembly for nanomedicine construction through enhanced programmability, improved stability and higher iron loading, thereby advancing ferroptosis‐related combination therapy and synergistic therapy.
- 17 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (35) , e71609
Open AccessFerritin‐Inspired Mineralized Iron Phosphate Nanominerals for Precision Ferroptosis–Immunotherapy via Controlled Iron Storage and Release
Ferroptosis provides promising method for tumor therapy but is limited by the low efficiency and safety concerns of conventional iron delivery systems. Herein, we report efficient ferritin‐mimetic nanominerals engineered via a small molecule‐mediated iron phosphate mineralization strategy, which emulates the natural iron storage and release processes to selectively trigger tumor ferroptosis. Using two ferroptosis inducers, palbociclib and Fin56, as model small molecules, the resulting nanominerals exhibit uniform size distribution, robust stability, and 72% iron incorporation efficiency, enabling precisely controlled ferrous ion release and dual‐drug co‐delivery within tumor tissues to achieve a triple amplification of ferroptosis. The amplified ferroptosis response further elicits a potent antitumor immune effect through immunogenic cell death, ultimately resulting in remarkable therapeutic efficacy with minimal side effects both in vitro and in vivo. This small molecule‐mediated iron phosphate mineralization strategy offers a superior alternative to traditional coordination self‐assembly for nanomedicine construction through enhanced programmability, improved stability and higher iron loading, thereby advancing ferroptosis‐related combination therapy and synergistic therapy.
- Open Access
- 5 May 2026
- Published by Elsevier in SSRN Electronic Journal
Sono-Responsive Self-Assembled Coppery Nanodrugs Amplify Cuproptosis for High-Efficiency Cancer Chemo-Immunotherapy
Cuproptosis-based therapy holds great promise in boosting systemic anti-tumor efficacy, especially when synergistically combined with sonodynamic therapy, which amplifies oxidative stress and offers superior tissue-penetration capabilities. In this study, a cuproptosis amplifier (DTX/TPPS-Cu) was developed through copper ion-mediated coordinative self-assembly of the sonosensitizer porphyrin (TPPS) and the chemotherapeutic agent docetaxel (DTX), aiming to boost cancer chemo-immunotherapy. DTX/TPPS-Cu nanoparticles internalized by tumor cells can be activated by intracellular glutathione (GSH) to release Cu⁺, which induces the oligomerization of lipoylated proteins, thereby triggering proteotoxic stress and irreversible cuproptosis. Upon ultrasound irradiation, the released TPPS generates a sonodynamic effect that further depletes excessive GSH, thereby preventing Cu⁺ chelation and amplifying cuproptosis in tumor cells, ultimately sensitizing DTX-mediated chemotherapy. More importantly, the significantly elevated reactive oxygen species levels and highly efficient cuproptosis contribute to the reversal of the immunosuppressive tumor microenvironment, thereby promoting immunogenic cell death and eliciting robust systemic anti-tumor immune responses for the tumor eradication. Thus, we propose a precisely regulated sonodynamic cuproptosis strategy to amplify chemo-immunotherapeutic efficacy, potentially heralding a new paradigm in cancer therapy.
- 5 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSono-Responsive Self-Assembled Coppery Nanodrugs Amplify Cuproptosis for High-Efficiency Cancer Chemo-Immunotherapy
Cuproptosis-based therapy holds great promise in boosting systemic anti-tumor efficacy, especially when synergistically combined with sonodynamic therapy, which amplifies oxidative stress and offers superior tissue-penetration capabilities. In this study, a cuproptosis amplifier (DTX/TPPS-Cu) was developed through copper ion-mediated coordinative self-assembly of the sonosensitizer porphyrin (TPPS) and the chemotherapeutic agent docetaxel (DTX), aiming to boost cancer chemo-immunotherapy. DTX/TPPS-Cu nanoparticles internalized by tumor cells can be activated by intracellular glutathione (GSH) to release Cu⁺, which induces the oligomerization of lipoylated proteins, thereby triggering proteotoxic stress and irreversible cuproptosis. Upon ultrasound irradiation, the released TPPS generates a sonodynamic effect that further depletes excessive GSH, thereby preventing Cu⁺ chelation and amplifying cuproptosis in tumor cells, ultimately sensitizing DTX-mediated chemotherapy. More importantly, the significantly elevated reactive oxygen species levels and highly efficient cuproptosis contribute to the reversal of the immunosuppressive tumor microenvironment, thereby promoting immunogenic cell death and eliciting robust systemic anti-tumor immune responses for the tumor eradication. Thus, we propose a precisely regulated sonodynamic cuproptosis strategy to amplify chemo-immunotherapeutic efficacy, potentially heralding a new paradigm in cancer therapy.
- 14 February 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (9) , e2403494
Control Over Kinetic Self‐Assembly of Phthalocyanine into Photothermal Nano‐Vaccine Enabling Tunable Superlarge Absorption Redshift
Supramolecular near‐infrared (NIR) nanomaterials show great application prospects in cancer photothermal immunotherapy. However, the direct self‐assembly of photothermal nanomaterials absorbed in biological transparent window and control over their absorption properties through aggregation behavior remains a grand challenge. Here, the control over superlarge absorption redshift (ranging from 105 nm to 150 nm) of mono‐α‐substituted carboxy zinc phthalocyanine (αZnPc) through kinetic assembly methodologies is demonstrated, resulting in the fabrication of photothermal nanoagents within tissue‐transparent NIR window. Tailoring the solvent polarity allows for the manipulation of kinetic pathways, leading to a variety of self‐assembled structures exhibiting distinct αZnPc macrocycle stacking modes that attribute to their different absorption redshift properties. Mechanistic studies of the relationship between solvent polarity and pathway complexity revealed the energy landscape that governs the unique kinetic behavior. The specific stacking mode and conformation conforming to the charge‐transfer model within these αZnPc assembled structures have been revealed by theoretical calculations. Crucially, the αZnPc nanostructures show remarkable physiological stability and robust photothermal performances within biological transparent window, efficiently ablating primary tumors and triggering immunogenic cell death. This effect is further augmented by the immunomodulatory effects of thymopentin, exhibiting vaccine‐like capabilities in suppressing the growth of distant tumors. This research demonstrates unprecedented levels of control over supramolecular structures and their superlarge red‐shifted absorption, providing great opportunities for future design and construction of supramolecular NIR materials with fascinating properties toward cancer treatments.
- 14 February 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (9) , e2403494
Control Over Kinetic Self‐Assembly of Phthalocyanine into Photothermal Nano‐Vaccine Enabling Tunable Superlarge Absorption Redshift
Supramolecular near‐infrared (NIR) nanomaterials show great application prospects in cancer photothermal immunotherapy. However, the direct self‐assembly of photothermal nanomaterials absorbed in biological transparent window and control over their absorption properties through aggregation behavior remains a grand challenge. Here, the control over superlarge absorption redshift (ranging from 105 nm to 150 nm) of mono‐α‐substituted carboxy zinc phthalocyanine (αZnPc) through kinetic assembly methodologies is demonstrated, resulting in the fabrication of photothermal nanoagents within tissue‐transparent NIR window. Tailoring the solvent polarity allows for the manipulation of kinetic pathways, leading to a variety of self‐assembled structures exhibiting distinct αZnPc macrocycle stacking modes that attribute to their different absorption redshift properties. Mechanistic studies of the relationship between solvent polarity and pathway complexity revealed the energy landscape that governs the unique kinetic behavior. The specific stacking mode and conformation conforming to the charge‐transfer model within these αZnPc assembled structures have been revealed by theoretical calculations. Crucially, the αZnPc nanostructures show remarkable physiological stability and robust photothermal performances within biological transparent window, efficiently ablating primary tumors and triggering immunogenic cell death. This effect is further augmented by the immunomodulatory effects of thymopentin, exhibiting vaccine‐like capabilities in suppressing the growth of distant tumors. This research demonstrates unprecedented levels of control over supramolecular structures and their superlarge red‐shifted absorption, providing great opportunities for future design and construction of supramolecular NIR materials with fascinating properties toward cancer treatments.
- 17 December 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (4) , e2403380
Glutathione Induced In Situ Activation of Dual‐Locked Cuproptosis Nanoamplifier with Glycolysis Metabolism Inhibition to Boost Cancer Immunotherapy
Interference with glycolysis metabolism not only promotes the efficient sensitization of cuproptosis, but also amplifies cytotoxic T cell functions and proliferations, thus contributing to relieve immunosuppressive tumor microenvironment. However, the synergistic mechanism and the design of multicomponent nanoformulations involving these three pathways have not yet been explored. a copper‐coordinated nanoassembly (designated as Cu‐GM) is reported here that integrates a lactate dehydrogenase inhibitor, galloflavin (GF), with an immune checkpoint inhibitor, myricetin (MY), to boost cancer cuproptosis‐immunotherapy. These results suggest that Cu‐GM can be activated by the endogenous overexpressed glutathione to release Cu+, leading to the abnormal aggregation of lipoylated proteins and iron‐sulfur cluster proteins loss, which triggers proteotoxic stress and cell cuproptosis. Meanwhile, the released GF not only inhibits the glycolysis to amplify cuproptosis efficacy but also achieves effective lactate depletion, thus alleviating immunosuppressive effects of lactate. Notably, the killed tumor cells can induce immunogenic cell death to evoke the anti‐tumor immunity, which further augmented by the MY‐mediated immune checkpoint blockade. Taken together, the first anticancer synergy of glycolysis metabolism, cuproptosis, and immunotherapy is presented, showcasing remarkable in vivo antitumor effects and encouraging further exploration of a rational multimodal treatment approach.
- 17 December 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (4) , e2403380
Glutathione Induced In Situ Activation of Dual‐Locked Cuproptosis Nanoamplifier with Glycolysis Metabolism Inhibition to Boost Cancer Immunotherapy
Interference with glycolysis metabolism not only promotes the efficient sensitization of cuproptosis, but also amplifies cytotoxic T cell functions and proliferations, thus contributing to relieve immunosuppressive tumor microenvironment. However, the synergistic mechanism and the design of multicomponent nanoformulations involving these three pathways have not yet been explored. a copper‐coordinated nanoassembly (designated as Cu‐GM) is reported here that integrates a lactate dehydrogenase inhibitor, galloflavin (GF), with an immune checkpoint inhibitor, myricetin (MY), to boost cancer cuproptosis‐immunotherapy. These results suggest that Cu‐GM can be activated by the endogenous overexpressed glutathione to release Cu+, leading to the abnormal aggregation of lipoylated proteins and iron‐sulfur cluster proteins loss, which triggers proteotoxic stress and cell cuproptosis. Meanwhile, the released GF not only inhibits the glycolysis to amplify cuproptosis efficacy but also achieves effective lactate depletion, thus alleviating immunosuppressive effects of lactate. Notably, the killed tumor cells can induce immunogenic cell death to evoke the anti‐tumor immunity, which further augmented by the MY‐mediated immune checkpoint blockade. Taken together, the first anticancer synergy of glycolysis metabolism, cuproptosis, and immunotherapy is presented, showcasing remarkable in vivo antitumor effects and encouraging further exploration of a rational multimodal treatment approach.
- 16 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-15
Mitochondria- and anaerobic glycolysis-targeted self-assembled copper complex nanoparticles for boosting cuproptosis-immunotherapy
- 16 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-15
Mitochondria- and anaerobic glycolysis-targeted self-assembled copper complex nanoparticles for boosting cuproptosis-immunotherapy
- 7 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-13
Dual natural enzyme-tuned biomineralized nanoflowers for boosting cascade catalytic antibacterial therapy and relieving inflammation
- 7 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-13
Dual natural enzyme-tuned biomineralized nanoflowers for boosting cascade catalytic antibacterial therapy and relieving inflammation
- 4 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-16
Ultra-lightweight carbon nanocomposites as microwave absorber with high absorbing performance derived from flour
- 4 December 2024
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (1) , 1-16
Ultra-lightweight carbon nanocomposites as microwave absorber with high absorbing performance derived from flour
- 18 December 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 175, 341-352
Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy
- 18 December 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 175, 341-352
Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy